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Background
Adiponectin, leptin, and resistin are adipocyte-derived
secretory factors which have functions in immune
response, inflammation, endothelial function, overweight,
and insulin resistance. Recently, adipokines have been sug-
gested to contribute as inflammatory mediators of
migraine. Clinical studies reported increases of adiponec-
tin levels in migraineurs. Migraine pain severity and
response to treatment in episodic migraine are associated
with changes in both adiponectin and leptin concentra-
tions. In addition, receptors for these adipokines are
expressed in key structures implicated in migraine, includ-
ing the hypothalamus and the cerebral microvasculature.
The aim of this study was to investigate plasma concentra-
tions of adiponectin, leptin, and resistin in patients with
chronic migraine.
Materials and methods
Twenty-seven patients with chronic migraine (20 females,
7 males; mean age 49.1±9.0 yrs) were recruited at the
Department of Neuroscience “Rita Levi Montalcini”, Uni-
versity of Torino. All patients were diagnosed with chronic
migraine according to ICHD-III beta version criteria.
Thirty-four healthy subjects were used as control group
(20 females, 14 males; mean age 49.2 ± 12.8 yrs). Subjects
with obesity and diabetes were excluded from the study.
Plasmatic levels of total adiponectin, leptin, and resistin
were measured by immunoassays. Fasting glucose, insulin,
total and HDL-cholesterol, triglycerides were also evalu-
ated. The clinical characteristics of migraine were col-
lected. Statistical analysis was performed using SPSS
version 20.
Results
Serum levels of adiponectin were significantly increased
in chronic migraineurs when compared with controls
(p = 0.002). After adjusting for BMI, there was no signif-
icant difference in leptin concentrations between the
two groups. However, a significant positive correlation
between leptin and basal insulin (r = +0.618, p = 0.002)
was found in patients with chronic migraine. Finally,
serum concentrations of resistin were significantly
increased in female patients with chronic migraine in
comparison with female controls (p = 0.03).
Discussion
Our study provides evidence that, in addition to episodic
migraine, adipokines may be involved also in chronic
migraine, supporting the hypothesis that these peptides
could represent potential novel biomarkers for the disease.
Further studies are needed in order to better elucidate the
neurobiological mechanisms underlying adipokines dys-
function in both episodic and chronic migraine.
Written informed consent to publication was obtained
from the patient(s).
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